Bromine in PDB 5ai9: Ligand Complex Structure of Soluble Epoxide Hydrolase

All present enzymatic activity of Ligand Complex Structure of Soluble Epoxide Hydrolase:
3.1.3.76; 3.3.2.10;

The structure of Ligand Complex Structure of Soluble Epoxide Hydrolase, PDB code: 5ai9 was solved by L.Oster, S.Tapani, Y.Xue, H.Kack, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	48.55 / 1.80
Space group	P 65 2 2
Cell size a, b, c (Å), α, β, γ (°)	92.709, 92.709, 243.850, 90.00, 90.00, 120.00
R / Rfree (%)	18.94 / 22.98

The binding sites of Bromine atom in the Ligand Complex Structure of Soluble Epoxide Hydrolase (pdb code 5ai9). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Ligand Complex Structure of Soluble Epoxide Hydrolase, PDB code: 5ai9:

Bromine binding site 1 out of 1 in the Ligand Complex Structure of Soluble Epoxide Hydrolase


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Ligand Complex Structure of Soluble Epoxide Hydrolase within 5.0Å range: probe atom residue distance (Å) B Occ A:Br1552 b:35.5 occ:1.00 BR A:K781552 0.0 35.5 1.0 C9 A:K781552 1.9 33.2 1.0 C8 A:K781552 2.9 31.2 1.0 C10 A:K781552 2.9 33.1 1.0 O12 A:K781552 3.0 30.1 1.0 O A:HOH2568 3.0 38.2 1.0 OD1 A:ASP496 3.4 21.8 1.0 O A:HOH2211 3.5 65.5 1.0 CB A:HIS524 3.7 16.6 1.0 CG2 A:VAL498 3.7 28.8 1.0 CB A:VAL498 4.0 28.6 1.0 CG A:HIS524 4.0 18.6 1.0 N A:VAL498 4.1 24.4 1.0 C7 A:K781552 4.2 31.4 1.0 C5 A:K781552 4.2 34.1 1.0 CG A:ASP496 4.3 24.2 1.0 ND1 A:HIS524 4.3 20.1 1.0 O A:HOH2601 4.3 27.6 1.0 N A:PHE497 4.4 25.8 1.0 SD A:MET419 4.4 69.3 1.0 CE A:MET419 4.6 66.3 1.0 C6 A:K781552 4.7 35.2 1.0 CA A:VAL498 4.7 23.7 1.0 OD2 A:ASP496 4.7 22.5 1.0 CD2 A:HIS524 4.9 19.8 1.0 CA A:HIS524 4.9 16.0 1.0 C A:PHE497 4.9 28.5 1.0 C A:ASP496 5.0 26.7 1.0

L.Oster, S.Tapani, Y.Xue, H.Kack. Successful Generation of Structural Information For Fragment-Based Drug Discovery. Drug Discov Today 2015.
ISSN: ESSN 1878-5832
PubMed: 25931264
DOI: 10.1016/J.DRUDIS.2015.04.005